Observational Copenhagen Pancreatic Cancer Study

ConditionPancreatic Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeNot listed

SponsorInna Chen, MD

About this trial

The primary objective of the Copenhagen Pancreatic Cancer (COPAN) study is to describe the real-world population of patients with pancreatic cancer (PC). Larger sample of longitudinal real-world data provides a unique opportunity for comprehensive exploration of the diagnostic and treatment journey for individuals diagnosed with PC and allows to investigate treatment outcomes and associated prognostic factors. Furthermore, the study aims to identify determinants of treatment management and treatment outcomes, including patient-reported outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

All patients with pancreatic cancer referred to Department of Oncology, Herlev Hospital, Denmark within the study period will be invited to participate.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

8,000 Participants

are grouped into 1 trial group

Group A: Patients with PC are referred to Comprehensive Pancreatic Cancer Center at Herlev Hospital

Trial outcomes

Primary outcomes

Overall survival

Time frame

3 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Inna Chen, MD

Lead sponsor

Herlev Hospital

Sponsor institution

Source ClinicalTrials.gov

Apply now